Arbiom’s Biotechnology Center, located outside of Paris in Evry, France, develops proprietary enzyme cocktails tailored to the Arbiom pretreatment process using its proprietary Massive Mutagenesis platform. Current enzyme cocktails face the challenge of enzymatically converting predominantly crystalline cellulose to glucose (C6 sugar), which is difficult for today’s commercial enzyme cocktails. Arbiom’s phosphoric acid process manufactures highly reactive, amorphous cellulose that is more easily hydrolyzed by enzymes to glucose. This technological advantage makes Arbiom enzyme cocktail optimization and complexity simpler and lowers enzyme cocktail cost.